Neuroimaging in Psychiatry

Neurologic Clinics

Volumn 27, Issue 1, 2009, Pages 237-249

  Capote, Horacio A ^a,b  

^a DENT NEUROLOGIC INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anxiety disorders; Biological psychiatry; Cognitive disorders; Magnetic resonance imaging; Mood disorders; Psychotic disorders; Radionuclide imaging; Substance related disorders; Tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LITHIUM; VALPROIC ACID;

ADDICTION; ANXIETY DISORDER; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; COGNITIVE DEFECT; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

BRAIN; DIAGNOSTIC IMAGING; HUMANS; MENTAL DISORDERS; PSYCHIATRY;

EID: 56849097637     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.09.011     Document Type: Review

References (60)

1. McCann D.J. The use of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders. Clin Pharmacol Ther 83 4 (2008) 627-630
2. Agartz I., Shoaf S., Rawlings R.R., et al. CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Psychiatry Res 122 1 (2003) 21-35
3. Lee E., Jang D.P., Kim J.J., et al. Alteration of brain metabolites in young alcoholics without structural changes. Neuroreport 18 14 (2007) 1511-1514
4. Gilman J.M., Ramchandani V.A., Davis M.B., et al. Why we like to drink: an fMRI study of the rewarding and anxiolytic effects of alcohol. J Neurosci 28 18 (2008) 583-591
5. Garcia-Valdecasas-Campelo E., Gonzalez-Reimers E., Santolaria-Fernandez F., et al. Brain atrophy in alcoholics: relationship with alcohol intake; liver disease; nutritional status, and inflammation. Alcohol Alcohol (2007) 10.1093/alcalc/agm065
6. Cardenas V.A., Ezekiel F., DiScalfani V., et al. Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images. Psychiatry Res 106 3 (2001) 193-205
7. DSM-IV-TR, American Psychiatric Association [APA]; 2000.
8. Campbell-Meiklejohn D.A., Woolrich M.W., Passingham R.E., et al. Knowing when to stop: the brain mechanisms of chasing losses. Biol Psychiatry 63 3 (2008) 293-300
9. Brown J.W., and Braver T.S. Risk prediction and aversion by anterior cingulate cortex. Cogn Affect Behav Neurosci 7 4 (2007) 266-277
10. Rivkin M.J., Davis P.E., Lemaster J.L., et al. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 121 4 (2008) 741-750
11. Rao H., Wang J., Giannetta J., et al. Altered resting cerebral blood flow with in utero cocaine exposure revealed by perfusion functional MRI. Pediatrics 120 5 (2007) e1245-e1254
12. Sim M.E., Lyoo I.K., Streeter C.C., et al. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 32 10 (2007) 2229-2237
13. Goldstein R., Tomasi D., Rajaram S., et al. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144 4 (2007) 1153-1159
14. Goldstein R.Z., and Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159 (2002) 1642-1652
15. De Bellis M.D., Keshavan M.S., Shifflett H., et al. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry 51 7 (2002) 553-562
16. Simmons A., Matthews S.C., Paulus M.P., et al. Intolerance of uncertainty correlates with insula activation during affective ambiguity. Neurosci Lett 430 2 (2008) 92-97
17. Whalen P.J., Johnstone T., Somerville L.H., et al. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry 63 9 (2008) 858-863
18. McClure E.B., Adler A., Monk C.S., et al. FMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology 191 1 (2007) 97-105
19. Baxter Jr. L.R., Phelps M.E., Mazziotta J.C., et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 50 6 (1993) 498-501
20. Gilbert A.R., Keshavan M.S., Diwadkar V., et al. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett 435 1 (2008) 45-50
21. Gilbert AR, Mataix-Cols D, Almeida JR, et al. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord [Epub ahead of print].
22. Saxena S, Gorbis E, O'Neill J, et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry [Epub ahead of print].
23. Shin L.M., Rauch S.L., and Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 1071 (2006) 67-79
24. De Bellis M.D., and Kuchibhatla M. Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry 60 7 (2006) 697-703
25. Carrion V.G., Weems C.F., and Reiss A.L. Stress predicts brain changes in children: a pilot longitudinal study on youth stress, posttraumatic stress disorder, and the hippocampus. Pediatrics 119 3 (2007) 509-516
26. Koenigs M., Huey E.D., Raymont V., et al. Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nat Neurosci 11 2 (2008) 232-237
27. Geuze E., Westenberg H.G., Jochims A., et al. Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry 64 1 (2007) 76-85
28. Berkowitz R.L., Coplan J.D., Reddy D.P., et al. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci 18 3-4 (2007) 191-207
29. Pardo J.V., Lee J.T., Sheikh S.A., et al. Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging. Neuroimage 35 3 (2007) 1231-1237
30. Teipel S.J., Born C., Ewers M., et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 38 1 (2007) 13-24
31. Foster N.L., Heidebrink J.L., Clark C.M., et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130 Pt 10 (2007) 2616-2635
32. Mosconi L., Tsui W.H., Herholz K., et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49 3 (2008) 390-398
33. Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur J Nucl Med Mol Imaging 35 Suppl 1 (2008) S46-S50
34. Rowe C.C., Ng S., Ackermann U., et al. Imaging beta-amyloid burden in aging and dementia. Neurology 68 20 (2007) 1718-1725
35. Pike K.E., Savage G., Villlemagne V.L., et al. Beta-amyloid imaging in non-demented individuals: evidence for pre-clinical Alzheimer's disease. Brain 130 pt 11 (2007) 2837-2844
36. Kemppainen N.M., Alto S., Karrasch M., et al. Cognitive reserve hypothesis: Pittsburgh compound band fllurodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 63 1 (2008) 112-118
37. Benisty S., Hernandez K., Viswanathan A., et al. Diagnostic criteria of vascular dementia in CADASIL. Stroke 39 3 (2008) 838-844
38. Tang W.K., Chan S.S., Chui H.F., et al. Impact of applying NINDS-AIREN criteria of probable vascular dementia to clinical and radiological characteristics of a stroke cohort with dementia. Cerebrovasc Dis 18 2 (2004) 98-103
39. Bastos-Leite A.J., van der Flier W.M., van Srtaaten E.C., et al. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 38 12 (2007) 3182-3185
40. Sachdev P.S., Brodaty H., Valenzuela M.J., et al. Clinical determinats of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord 21 5-6 (2006) 275-283
41. Yurgelun-Todd D.A., Sava S., and Dahlgren M.K. Mood disorders. Neuroimaging Clin N Am 17 4 (2007) 511-521 ix
42. Hasler G., van der Veen J.W., Tumonis T., et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 2 (2007) 193-200
43. Ende G., Demirakca T., Walter S., et al. Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 257 1 (2007) 36-39
44. Matsuo K., Glahn D.C., Peluso M.A., et al. Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Mol Psychiatry 12 2 (2007) 158-166
45. Bragulat V., Paillere-Martinot M.L., Artiges E., et al. Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis. Psychiatry Res 154 2 (2007) 115-124
46. Phillips M.L., and Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull 33 4 (2007) 893-904
47. Javadapour A., Malhi G.S., Ivanovski B., et al. Increased anterior cingulate cortex volume in bipolar I disorder. Aust N Z J Psychiatry 41 11 (2007) 910-916
48. Bearden CE, Soares JC, Klunder AD, et al. Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry [Epub ahead of print].
49. Foland L.C., Altshuler L.L., Bookheimer S.Y., et al. Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res 162 1 (2008) 27-37
50. Wessa M., Houenou J., Paillere-Martinot M.L., et al. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/no go task. Am J Psychiatry 164 4 (2007) 638-646
51. Mahl L., Zarate Jr. C.A., Singh J., et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry. 61 1 (2007) 765-775
52. Tebartz van Elst L., Hesslinger B., Thiel T., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry 54 (2003) 163-171
53. Herpetz S.C., Dietrich T.M., Wenning B., et al. Evidence of abnormal amygdale functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry 50 (2001) 292-298
54. Grant J.E., Correia S., Brennan-Krohn T., et al. Frontal white matter integrity in borderline personality disorder with self-injurious behavior. J Neuropsychiatry Clin Neurosci 19 (2007) 383-390
55. Baiano M, Perlini C, Rambaldelli G, et al. Decreased entorhinal cortex volumes in schizophrenia. Schizophr Res [Epub ahead of print].
56. Reig S, Moreno C, Moreno D, et al. Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull [Epub ahead of print].
57. Arrango C., Moreno C., Martinez S., et al. Longintudinal brain changes in early-onset psychosis. Schizophr Bull. 34 2 (2008) 341-353
58. Zipaparo L., Whitford T.J., Redoblado Hodge M.A., et al. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 32 2 (2008) 531-538
59. Fornito A., Yucel M., Wood S.J., et al. Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp. 29 4 (2008) 478-489
60. Schlosser R.G., Koch K., Wagner G., et al. Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study. Neuropsychologia 46 1 (2008) 336-347